Angioimmunoblastic Lymphadenopathy
1 clinical trials · Condition
◉ Watch Angioimmunoblastic Lymphadenopathy
| Record | Firm | Date |
|---|---|---|
| Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP (NCT00725231) | University of Göttingen | 2008-02-01 |
Track Angioimmunoblastic Lymphadenopathy automatically
Every clearance here is in the API, with alerts when new ones post.